Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression

Table 2 Comparison of clinical and genetic features between XIST-high and XIST-low groups

	XIST		P
	High (n = 31)	Low (n = 31)	P
Age	30.23 ± 9.45	33.74 ± 10.35	0.1683
White blood cell	31.6 ± 17.29	41.56 ± 26.51	0.0849
Platelet	69.75 ± 10.97	64.46 ± 13.12	0.0902
Hemoglobin	8.83 ± 1.57	8.37 ± 2.04	0.3238
FAB			0.0018
M₃	6	18
Non-M₃	25	13
Risk stratification of cytogenetics			0.0173
Good	5	15
Intermediate	11	9
Poor	15	7

ISSN: 1528-3658